Codes and Frequencies
SEFEARFACE reports whether the woman is concerned about facial spotting as a side effect of a contraceptive method. See comparability tab for important information on differences in the universe parameters for each sample.
Users should be careful to distinguish this variable from FPSEFACE which indicates whether the woman has experienced facial spotting as a side effect of using a contraceptive method. SEHEARDFACE indicates whether the woman has heard about or experienced facial spotting as a side effect of a contraceptive method.
This question associated with this variable was included in the female questionnaire.
For the Uganda 2018 sample, this variable reports a concern held by any woman aged 15-49, provided that she had experienced or heard about any side effect related to a method of contraception. Hence, the universe for the Uganda 2018 sample is not restricted to women who have used contraception in the past. For the Ethiopia 2019 sample, this variable includes only women aged 15-49 who are currently using (or whose partner is using) a method of contraception, and who have heard about - but not experienced - side effects related to that method.
- Burkina Faso 2018 Round 6 Female and Household: Women aged 15-49 who have experienced or heard about any side effects of a contraceptive method.
- Ethiopia 2019 PMAET Female and Household: Women aged 15-49 who are worried about, but not experiencing, side effects related to a method of contraception that they or their partner are currently using.
- Burkina Faso: 2018
- Ethiopia: 2019